Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Current Assets (2016 - 2025)

Macrogenics (MGNX) has disclosed Current Assets for 14 consecutive years, with $219.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Current Assets rose 1.13% to $219.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $219.9 million, a 1.13% increase, with the full-year FY2025 number at $219.9 million, up 1.13% from a year prior.
  • Current Assets was $219.9 million for Q4 2025 at Macrogenics, down from $232.1 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $374.7 million in Q1 2021 to a low of $147.8 million in Q3 2022.
  • A 5-year average of $241.8 million and a median of $222.2 million in 2022 define the central range for Current Assets.
  • Peak YoY movement for Current Assets: plummeted 55.84% in 2022, then soared 97.09% in 2023.
  • Macrogenics' Current Assets stood at $279.6 million in 2021, then fell by 20.53% to $222.2 million in 2022, then rose by 13.12% to $251.3 million in 2023, then decreased by 13.47% to $217.5 million in 2024, then rose by 1.13% to $219.9 million in 2025.
  • Per Business Quant, the three most recent readings for MGNX's Current Assets are $219.9 million (Q4 2025), $232.1 million (Q3 2025), and $204.9 million (Q2 2025).